Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 71 Magnetic Resonance Spectroscopy 55 Biopsy 43 pembrolizumab 25 Carboplatin 25 Radiation 24 Radiotherapy 23 Cyclophosphamide 23 Nivolumab 21 Paclitaxel 20 Cisplatin 20 olaparib 18 Etoposide 18 Doxorubicin 17 X-Rays 16 Vincristine 16 Taxes 15 Immunoglobulin G 15 Disulfides 15 Radiotherapy, Intensity-Modulated 14 Leucovorin 14 Dexamethasone 14 Cytarabine 14 Bevacizumab 14 durvalumab 13 Prednisone 13 Platinum 13 1,2-diaminocyclohexaneplatinum II citrate 13 Methotrexate 11 Ipilimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × NPI 2358 × 30 days × Clear all

NCT02504489 2026-05-19

DUBLIN-3

BeyondSpring Pharmaceuticals Inc.

Phase 3 Completed

559 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡